Terveystalo Oy (TTALO)
Helsinki Exchange · Finland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 6.270 |
|---|---|
| 52-week range | 6.090 – 10.420 |
| Return, 1 month / 3 months | −14.9% / −6.8% |
| Return, 1 year / 3 years | −32.5% / −3.8% |
| Trend | Below its 200-day average |
| RSI (14) | 20 |
| Volatility (1 year) | 25.7% |
| Worst drawdown (1 year) | -34.3% |
| Average daily value traded | 1.99M EUR |
| Dividend yield | 10.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Terveystalo Oy is a private healthcare services company based in Finland. It runs a network of clinics and hospitals that provide occupational health services, general practitioner and specialist medical care, diagnostics and related health services. Its customers include employers that arrange occupational healthcare for their staff, insurance companies and private individuals who pay for appointments and treatment directly. The company also works with public sector organisations that purchase healthcare services from private providers.
On this site Terveystalo Oy appears as a stock on the Helsinki Exchange (Finland), code TTALO, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Terveystalo Oy (TTALO) trades on the Helsinki Exchange in Finland. It last closed at EUR 6.270 on 22 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 103 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 32.5% and over the last three months it fell 6.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Helsinki Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.7% | ||
| From 52-week high | -39.4% | ||
| Momentum | 24 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.8% | ||
| 6-month return | -20.6% | ||
| 12-month return, skipping the last month | -20.6% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.3% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 1.99M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 96 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 10.2% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −11.4% |
|---|---|
| 1 month | −14.9% |
| 3 months | −6.8% |
| 6 months | −20.6% |
| 1 year | −32.5% |
| 3 years | −3.8% |
| 5 years | −30.8% |
Signals
| 50-day / 200-day average | 7.214 / 7.805 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.184 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Oct 2026 | EUR 0.3200 |
| 25 Mar 2026 | EUR 0.3200 |
| 7 Oct 2025 | EUR 0.2400 |
| 9 Apr 2025 | EUR 0.2400 |
| 8 Oct 2024 | EUR 0.1500 |
| 27 Mar 2024 | EUR 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Helsinki Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.